John Heymach | BiotechTV

top of page

Houston Oncology Summit: MD Anderson's John Heymach, a leading expert in lung cancer, talks about the latest in TKI's, KRAS, Bi-specifics, and more

John Heymach gives an overview of how TKIs are progressing in the EGFR and HER2 space, his thoughts on the recent VEGF x PD1 data that...

Bright Minds

Sep 26, 2024

Houston Oncology Summit: Talking lung cancer advances with John Heymach

Dr. Heymach discusses KRAS, refined TKI matching, antibody-drug conjugates, cell therapies, and cancer vaccines.

Bright Minds

Sep 21, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Houston Oncology Summit: MD Anderson's John Heymach, a leading expert in lung cancer, talks about the latest in TKI's, KRAS, Bi-specifics, and more

Houston Oncology Summit: Talking lung cancer advances with John Heymach

Follow BiotechTV

Sponsors

Sponsor Spotlight